Skyhawk Therapeutics has expanded its global pivotal Phase 2/3 clinical [...]

Erasca has reported updated preliminary Phase 1 data for its [...]

Q32 Bio has reported positive 36-week Phase 2 data showing [...]

New Phase 1 data show Vandria’s VNA-318 reaches the human [...]

Poolbeg Pharma has dosed the first patient in a clinical [...]

Merck has received FDA Breakthrough Therapy designation for enpatoran, an [...]

Compass Pathways has reported positive six-month results from its second [...]

Novartis has agreed to acquire UK biotech Myricx Bio for [...]

Abivax has reported positive topline results from Part 2 of [...]

Telum Therapeutics has raised €18 million in a Series A [...]